LJMU10h
Evaluating the consistency of judgments derived through both in silico and expert application of the Cramer classification scheme
Firman, JW, Boobis, A, Hollnagel, HM, Kaiser, S, Lovell, DP, Moretto, A, Mueller, S, Rider, CV, Schmidt, F, Stice, S, ...
Nature1mon
In silico drug discovery: Tools for bridging the NCE gap
Can in silico drug discovery really supply the tools the pharmaceutical industry needs to meet its goals during the next decade? After all, other computer–based systems such as "rational drug ...
The Atlantic6y
The Virtual Body That Could Make Clinical Trials Unnecessary
The benefits of in silico modeling extend beyond the experimental ... “VPH-type models can provide a tool to integrate that information,” Geris said. “That can suggest things to the ...
Frontiers18d
AI, Bioinformatics, and In Silico Based Biomarkers for the Diagnosis and Treatment of Neurodegenerative Diseases
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), pose profound challenges in healthcare due to their progressive neuronal deterioration, which ...